Literature DB >> 15928247

REVIEW: Treatment of hypothyroidism with combinations of levothyroxine plus liothyronine.

Héctor F Escobar-Morreale1, José I Botella-Carretero, Francisco Escobar del Rey, Gabriella Morreale de Escobar.   

Abstract

CONTEXT: Combined infusion of levothyroxine plus liothyronine, as opposed to levothyroxine alone, is the only way of restoring the concentrations of circulating TSH, T4, and T3 as well as those of both T4 and T3 in all tissues of thyroidectomized rats. Considering the substantial differences in thyroid hormone secretion, transport, and metabolism between rats and humans, whether or not combined levothyroxine plus liothyronine replacement therapy has advantages over treatment with levothyroxine alone in hypothyroid patients is still questioned. EVIDENCE ACQUISITION: We conducted a systematic review of all the published controlled studies comparing treatment with levothyroxine alone with combinations of levothyroxine plus liothyronine in hypothyroid patients, identified through the Entrez-PubMed search engine. EVIDENCE SYNTHESIS: Nine controlled clinical trials were identified that compared treatment with levothyroxine alone and treatment with combinations of levothyroxine plus liothyronine and included a sufficient number of adult hypothyroid patients to yield meaningful results. In only one study did the combined therapy appear to have beneficial effects on the mood, quality of life, and psychometric performance of the patients over levothyroxine alone. These results have not been confirmed by later studies using either T3 substitution protocols or approaches with fixed combinations of levothyroxine plus liothyronine, including those based on the physiological proportion in which T3 and T4 are secreted by the human thyroid. However, in some of these studies the patients preferred levothyroxine plus liothyronine combinations, for reasons not explained by changes in the psychological and psychometric tests employed. Yet patients' preference should be balanced against the possibility of adverse events resulting from the addition of liothyronine to levothyroxine, even in the small doses used in these studies.
CONCLUSIONS: Until clear advantages of levothyroxine plus liothyronine are demonstrated, the administration of levothyroxine alone should remain the treatment of choice for replacement therapy of hypothyroidism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15928247     DOI: 10.1210/jc.2005-0184

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  29 in total

Review 1.  Persistent hypothyroid symptoms in a patient with a normal thyroid stimulating hormone level.

Authors:  Jacqueline Jonklaas
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2017-10       Impact factor: 3.243

2.  Cognitive functioning and quality of life in patients with Hashimoto thyroiditis on long-term levothyroxine replacement.

Authors:  Marina Djurovic; Alberto M Pereira; Johannes W A Smit; Olga Vasovic; Svetozar Damjanovic; Zvezdana Jemuovic; Dragan Pavlovic; Dragana Miljic; Sandra Pekic; Marko Stojanovic; Milika Asanin; Gordana Krljanac; Milan Petakov
Journal:  Endocrine       Date:  2018-06-29       Impact factor: 3.633

3.  Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.

Authors:  Jacqueline Jonklaas; Antonio C Bianco; Andrew J Bauer; Kenneth D Burman; Anne R Cappola; Francesco S Celi; David S Cooper; Brian W Kim; Robin P Peeters; M Sara Rosenthal; Anna M Sawka
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

Review 4.  Paradigm shifts in thyroid hormone replacement therapies for hypothyroidism.

Authors:  Wilmar M Wiersinga
Journal:  Nat Rev Endocrinol       Date:  2014-01-14       Impact factor: 43.330

Review 5.  The emergence of levothyroxine as a treatment for hypothyroidism.

Authors:  James V Hennessey
Journal:  Endocrine       Date:  2016-12-16       Impact factor: 3.633

6.  Thyroid function within the normal range and risk of coronary heart disease: an individual participant data analysis of 14 cohorts.

Authors:  Bjørn O Åsvold; Lars J Vatten; Trine Bjøro; Douglas C Bauer; Alexandra Bremner; Anne R Cappola; Graziano Ceresini; Wendy P J den Elzen; Luigi Ferrucci; Oscar H Franco; Jayne A Franklyn; Jacobijn Gussekloo; Giorgio Iervasi; Misa Imaizumi; Patricia M Kearney; Kay-Tee Khaw; Rui M B Maciel; Anne B Newman; Robin P Peeters; Bruce M Psaty; Salman Razvi; José A Sgarbi; David J Stott; Stella Trompet; Mark P J Vanderpump; Henry Völzke; John P Walsh; Rudi G J Westendorp; Nicolas Rodondi
Journal:  JAMA Intern Med       Date:  2015-06       Impact factor: 21.873

Review 7.  Hormone replacement after thyroid and parathyroid surgery.

Authors:  Andreas Schäffler
Journal:  Dtsch Arztebl Int       Date:  2010-11-26       Impact factor: 5.594

8.  2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism.

Authors:  Wilmar M Wiersinga; Leonidas Duntas; Valentin Fadeyev; Birte Nygaard; Mark P J Vanderpump
Journal:  Eur Thyroid J       Date:  2012-06-13

9.  Physician Choice of Hypothyroidism Therapy: Influence of Patient Characteristics.

Authors:  Jacqueline Jonklaas; Eshetu Tefera; Nawar Shara
Journal:  Thyroid       Date:  2018-11       Impact factor: 6.568

Review 10.  [Substitution of thyroid hormones].

Authors:  R Gärtner; M Reincke
Journal:  Internist (Berl)       Date:  2008-05       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.